These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 7868061)
21. [Change in aldolase activity in the organs of mice in the process of hepatoma 22a development]. Treshchenkova IuA Vopr Med Khim; 1979; 25(5):607-11. PubMed ID: 494546 [TBL] [Abstract][Full Text] [Related]
22. [Aldolase- and hexokinase-isoenzymes in hepatoma]. Sato S Nihon Ishikai Zasshi; 1969 Dec; 62(12):1217-26. PubMed ID: 4312118 [No Abstract] [Full Text] [Related]
23. Resurgence of fetal isozymes in cancer: study of aldolase, pyruvate kinase, lactic dehydrogenase, and beta-hexosaminidase. Schapira F Isozymes Curr Top Biol Med Res; 1981; 5():27-75. PubMed ID: 6276331 [No Abstract] [Full Text] [Related]
24. Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization. Kawaguchi K; Honda M; Yamashita T; Shirota Y; Kaneko S Biochem Biophys Res Commun; 2005 Apr; 329(1):370-80. PubMed ID: 15721316 [TBL] [Abstract][Full Text] [Related]
25. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985 [TBL] [Abstract][Full Text] [Related]
26. [Expression of MAGE-A1 in human hepatoma cell lines associated with genic hypomethylation]. Xiao J; Chen HS; Fei R; Cong X; Wang Y; Jiang D; Wei L; Wang Y Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):351-4. PubMed ID: 15918969 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene. Laird AD; Brown PI; Fausto N Cancer Res; 1994 Aug; 54(15):4224-32. PubMed ID: 8033155 [TBL] [Abstract][Full Text] [Related]
28. Isozyme profiles of oval cells, parenchymal cells, and biliary cells isolated by centrifugal elutriation from normal and preneoplastic livers. Hayner NT; Braun L; Yaswen P; Brooks M; Fausto N Cancer Res; 1984 Jan; 44(1):332-8. PubMed ID: 6690044 [TBL] [Abstract][Full Text] [Related]
29. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation. Wang SY; Chen LY; Tsai TF; Su TS; Choo KB; Ho CK Exp Hematol; 1996 Feb; 24(3):437-44. PubMed ID: 8599973 [TBL] [Abstract][Full Text] [Related]
30. Alteration of aldolase isozymes in serum and tissues of patients with cancer and other diseases. Asaka M; Kimura T; Meguro T; Kato M; Kudo M; Miyazaki T; Alpert E J Clin Lab Anal; 1994; 8(3):144-8. PubMed ID: 8046542 [TBL] [Abstract][Full Text] [Related]
31. Growth-arrested dependence of aldolase A L-type mRNA expression in rodent cell lines. Lupo A; Costanzo P; De Rosa M; Russo T; Salvatore F; Izzo P Exp Cell Res; 1994 Aug; 213(2):359-64. PubMed ID: 8050493 [TBL] [Abstract][Full Text] [Related]
32. [p53 gene expression of human hepatoma cell lines and their sensitivities to parvovirus H-1]. Guo LP; Li GD; Xu H; Huang QS; Lin WM; Ling WH; Huang H; Luo ZY; Su ZZ Shi Yan Sheng Wu Xue Bao; 1999 Mar; 32(1):23-9. PubMed ID: 12548791 [TBL] [Abstract][Full Text] [Related]
33. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
34. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Masuhara M; Yasunaga M; Tanigawa K; Tamura F; Yamashita S; Sakaida I; Okita K Hepatology; 1996 Aug; 24(2):323-9. PubMed ID: 8690400 [TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Tacchini L; De Ponti C; Matteucci E; Follis R; Desiderio MA Carcinogenesis; 2004 Nov; 25(11):2089-100. PubMed ID: 15240510 [TBL] [Abstract][Full Text] [Related]
36. Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines. Shu HJ; Saito T; Watanabe H; Ito JI; Takeda H; Okano H; Kawata S Biochem Biophys Res Commun; 2002 Apr; 293(1):150-4. PubMed ID: 12054577 [TBL] [Abstract][Full Text] [Related]
37. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells. Damdinsuren B; Nagano H; Kondo M; Natsag J; Hanada H; Nakamura M; Wada H; Kato H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M Oncol Rep; 2006 Feb; 15(2):401-8. PubMed ID: 16391861 [TBL] [Abstract][Full Text] [Related]
38. Expression of differentiated functions in hepatoma cell hybrids. II. Aldolase. Bertolotti R; Weiss MC J Cell Physiol; 1972 Apr; 79(2):211-24. PubMed ID: 4337360 [No Abstract] [Full Text] [Related]
39. The alteration of cytokeratin 18 molecule and its mRNA expression during tumor transformation in hepatoma. Liu YH; Pei RJ; Yeh CC; Lee KY; Yeh KT; Hsu YH; Ho CC; Lai YS Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):243-53. PubMed ID: 9261884 [TBL] [Abstract][Full Text] [Related]
40. Expression of aldolase A messenger RNAs in human adult and foetal tissues and in hepatoma. Mennecier F; Daegelen D; Schweighoffer F; Levin M; Kahn A Biochem Biophys Res Commun; 1986 Feb; 134(3):1093-100. PubMed ID: 3004482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]